These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10935646)

  • 1. Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 2000 Aug; 24(8):1058-67. PubMed ID: 10935646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.
    Goldstein NS; Vicini FA; Kestin LL; Thomas M
    Cancer; 2000 Jun; 88(11):2553-60. PubMed ID: 10861433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
    Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
    Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 1999 Nov; 23(11):1340-8. PubMed ID: 10555002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast.
    Goldstein NS; Lacerna M; Vicini F
    Am J Clin Pathol; 1998 Sep; 110(3):357-67. PubMed ID: 9728611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy.
    Vicini FA; Lacerna MD; Goldstein NS; Horwitz EM; Dmuchowski CF; White JR; Gustafson GS; Ingold JA; Martinez AA
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):627-35. PubMed ID: 9336142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.
    Solin LJ; Yeh IT; Kurtz J; Fourquet A; Recht A; Kuske R; McCormick B; Cross MA; Schultz DJ; Amalric R
    Cancer; 1993 Apr; 71(8):2532-42. PubMed ID: 8384070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.
    Rodrigues N; Carter D; Dillon D; Parisot N; Choi DH; Haffty BG
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1331-5. PubMed ID: 12459354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.
    Vicini FA; Kestin LL; Goldstein NS; Baglan KL; Pettinga JE; Martinez AA
    J Surg Oncol; 2001 Apr; 76(4):245-54. PubMed ID: 11320515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS).
    Fowble B; Hanlon AL; Fein DA; Hoffman JP; Sigurdson ER; Patchefsky A; Kessler H
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):949-57. PubMed ID: 9276359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy.
    Vicini FA; Goldstein NS; Kestin LL
    Ann Oncol; 1999 Aug; 10(8):883-90. PubMed ID: 10509147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.
    Kestin LL; Goldstein NS; Martinez AA; Rebner M; Balasubramaniam M; Frazier RC; Register JT; Pettinga J; Vicini FA
    Ann Surg; 2000 Feb; 231(2):235-45. PubMed ID: 10674616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy.
    Rudloff U; Brogi E; Reiner AS; Goldberg JI; Brockway JP; Wynveen CA; McCormick B; Patil S; Van Zee KJ
    Ann Surg; 2010 Apr; 251(4):583-91. PubMed ID: 20224381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up.
    Perera F; Yu E; Engel J; Holliday R; Scott L; Chisela F; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1239-46. PubMed ID: 14630257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.
    Van Zee KJ; Liberman L; Samli B; Tran KN; McCormick B; Petrek JA; Rosen PP; Borgen PI
    Cancer; 1999 Nov; 86(9):1757-67. PubMed ID: 10547549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy.
    Bornstein BA; Recht A; Connolly JL; Schnitt SJ; Cady B; Koufman C; Love S; Osteen RT; Harris JR
    Cancer; 1991 Jan; 67(1):7-13. PubMed ID: 1845938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.